L

LTZ Therapeutics

16 employees

LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Medical

Date founded

2022

Funding rounds raised

Total raised

$17M

from 4 investors over 4 rounds

L

LTZ Therapeutics raised $10M on May 31, 2023

Investors: K2 Venture Capital and Qiming Venture Partners

L

LTZ Therapeutics raised $17M on April 7, 2022

Investors: Qiming Venture Partners and Tigermed

FAQ